INTERNATIONAL PATENT: NANJING REJU THERAPEUTICS, INC., 南京瑞初医药有限公司 FILES APPLICATION FOR "NICOTINAMIDE PHOSPHORIBOSYL TRANSFERASE AGONIST AND USE THEREOF"

GENEVA, May 5 -- NANJING REJU THERAPEUTICS, INC. (109-29, Building 6, Zhilan Road 18, Jiangning, (Jiangning High-tech Park)Nanjing, Jiangsu 210000), 南京瑞初医药有限公司 (中国江苏省南京市江宁区芝兰路18号6栋109-29（江宁高新园）) filed a patent application (PCT/CN2024/127307) for "NICOTINAMIDE PHOSPHORIBOSYL TRANSFERASE AGONIST AND USE THEREOF" on Oct 25, 2024. With publication no. WO/2025/087375, the details related to the patent application was published on May 01, 2025.

Notably, the patent application was submitted under the International Paten...